Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2014; 20(20): 6262-6278
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6262
Table 4 Recommendations for the use of pegylated interferon as initial antiviral therapy
HBV genotypeGeneral recommendations for HBeAg positive patients
AEither high ALT (≥ 2 × ULN) or low HBV DNA levels (< 9 log10 copies/mL)
B and CBoth high ALT (≥ 2 × ULN) and low HBV DNA levels (< 9 log10 copies/mL)
DNot recommended